Search

Your search keyword '"Baxter, David"' showing total 1,435 results

Search Constraints

Start Over You searched for: Author "Baxter, David" Remove constraint Author: "Baxter, David"
1,435 results on '"Baxter, David"'

Search Results

2. Proteomic changes induced by longevity-promoting interventions in mice

5. Author Correction: Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

7. Lifespan-extending interventions induce consistent patterns of fatty acid oxidation in mouse livers

13. An Operator Analysis of Contextuality Witness Measurements for Multimode-Entangled Single Neutron Interferometry

14. Probabilistic Data Association via Mixture Models for Robust Semantic SLAM

17. Persistence of immune responses after heterologous and homologous third COVID-19 vaccine dose schedules in the UK: eight-month analyses of the COV-BOOST trial

18. Embedded walls

19. SANS instrumental design considerations at CANS facilities

21. Compact ultracold neutron source concept for low energy accelerator-driven neutron sources

22. Blast Traumatic Brain Injury

23. SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

29. Erratum: Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling

30. Comprehensive multi-center assessment of small RNA-seq methods for quantitative miRNA profiling

31. Safety, immunogenicity, and reactogenicity of BNT162b2 and mRNA-1273 COVID-19 vaccines given as fourth-dose boosters following two doses of ChAdOx1 nCoV-19 or BNT162b2 and a third dose of BNT162b2 (COV-BOOST): a multicentre, blinded, phase 2, randomised trial

32. Persistence of immunogenicity after seven COVID-19 vaccines given as third dose boosters following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK: Three month analyses of the COV-BOOST trial.

33. Implementation of corticosteroids in treatment of COVID-19 in the ISARIC WHO Clinical Characterisation Protocol UK: prospective, cohort study

34. Safety, immunogenicity, and efficacy of a COVID-19 vaccine (NVX-CoV2373) co-administered with seasonal influenza vaccines: an exploratory substudy of a randomised, observer-blinded, placebo-controlled, phase 3 trial

35. Digitization protocol for scoring reproductive phenology from herbarium specimens of seed plants.

36. Safety and immunogenicity of seven COVID-19 vaccines as a third dose (booster) following two doses of ChAdOx1 nCov-19 or BNT162b2 in the UK (COV-BOOST): a blinded, multicentre, randomised, controlled, phase 2 trial

37. The impact of viral mutations on recognition by SARS-CoV-2 specific T cells

39. THE PREDICTIVE ROLE OF SYMPTOMS IN COVID-19 DIAGNOSTIC MODELS – A LONGITUDINAL INSIGHT

40. Knee

41. Characterisation of in-hospital complications associated with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol UK: a prospective, multicentre cohort study

42. Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study

43. Changes in in-hospital mortality in the first wave of COVID-19: a multicentre prospective observational cohort study using the WHO Clinical Characterisation Protocol UK

44. Risk of adverse outcomes in patients with underlying respiratory conditions admitted to hospital with COVID-19: a national, multicentre prospective cohort study using the ISARIC WHO Clinical Characterisation Protocol UK

45. Meningococcal carriage in periods of high and low invasive meningococcal disease incidence in the UK: comparison of UKMenCar1–4 cross-sectional survey results

46. Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study

47. Osteoid osteoma presenting with scoliosis: successful resection with endoscopic excision.

48. Effect of Combat Exposure and Posttraumatic Stress Disorder on Telomere Length and Amygdala Volume

Catalog

Books, media, physical & digital resources